(R)-2-((tert-Butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, 95+%, 250mg

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine, 95.0%, 100mg

(S)-N-(5,7-Difluoro-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-2,2,2-trifluoroacetamide, 95%, 100mg

(1,1,2-trimethylpropyl)amine, 95.0%, 250mg

(3R)-3-[4-(Trifluoromethyl)phenyl]morpholine, 98%, 1g

Vitamin K4>98.0%(GC)25g

Ethyl 2,5-dichlorobenzoate, 95.0%, 25g

[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](1,3-diphenyl-1,3-propanedionato)copper(I)>98.0%(T)1g

N-(Cyclohexylthio)phthalimide>98.0%(N)25g

Ceramic table (replaces the original table)

(r)-2-Amino-2-(3,5-dimethylphenyl)ethan-1-ol, 98%, 1g

H-Ala-OMe.HCl, 98%, 500g

8-Chloro-3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-amine, 95%, 1g